Increased expression and localization of cyclooxygenase-2 in astrocytes of scrapie-infected mice

Journal of Neuroimmunology

Volumn 187, Issue 1-2, 2007, Pages 74-82

  Kim, Jae Il ^a   Jin, Jae Kwang ^b   Choi, Eun Kyoung ^b   Spinner, Daryl ^a   Rubenstein, Richard ^a   Carp, Richard I ^a   Kim, Yong Sun ^b  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b Hallym University   (South Korea)

Author keywords

Cerebral inflammatory process; Cyclooxygenase 2; Prion; Reactive astrocytes; Scrapie

Indexed keywords

CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PRION PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN REGION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME ANALYSIS; ENZYME LOCALIZATION; IMMUNOHISTOLOGY; IMMUNOREACTIVITY; INFLAMMATION; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCRAPIE; STAINING; UPREGULATION;

ANIMALS; ASTROCYTES; BRAIN; CYCLOOXYGENASE 2; DINOPROSTONE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MALE; MICE; MICE, INBRED C57BL; NF-KAPPA B; PRIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCRAPIE;

EID: 34347221899     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.04.013     Document Type: Article

References (54)

1. Aucouturier P., Frangione B., and Wisniewski T. Prion diseases and the immune system. Ann. Med. Interne (Paris) 150 (1999) 75-78
2. Bauer M.K., Lieb K., Schulze-Osthoff K., Berger M., Gebicke-Haerter P.J., Bauer J., and Fiebich B.L. Expression and regulation of cyclooxygenase-2 in rat microglia. Eur. J. Biochem. 243 (1997) 726-731
3. Campbell I.L., Eddleston M., Kemper P., Oldstone M.B., and Hobbs M.V. Activation of cerebral cytokine gene expression and its correlation with onset of reactive astrocyte and acute-phase response gene expression in scrapie. J. Virol. 68 (1994) 2383-2387
4. Carp R.I., Kascsak R.J., Ye X., Kozlowski P.B., Kozielsk R., Diedrich J.F., and Haase A.T. Possible Roles for Astroglia and Microglia in the Pathogenesis of Unconventional Slow Infections (1993), Plenum Press, New York 417-429
5. Sc and infectivity-do the pieces fit?. Trends Neurosci. 17 (1994) 148-149
6. Casadesus G., Smith M.A., Basu S., Hua J., Capobianco D.E., Siedlak S.L., Zhu X., and Perry G. Increased isoprostane and prostaglandin are prominent in neurons in Alzheimer disease. Mol. Neurodegener. 2 (2007) 2
7. Chao C.C., Hu S., Sheng W.S., Bu D., Bukrinsky M.I., and Peterson P.K. Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism. Glia 16 (1996) 276-284
8. Choi S.I., Ju W.K., Choi E.K., Kim J., Lea H.Z., Carp R.I., Wisniewski H.M., and Kim Y.S. Mitochondrial dysfunction induced by oxidative stress in the brains of hamsters infected with the 263 K scrapie agent. Acta Neuropathol. (Berl) 96 (1998) 279-286
9. Choi Y.G., Kim J.I., Lee H.P., Jin J.K., Choi E.K., Carp R.I., and Kim Y.S. Induction of heme oxygenase-1 in the brains of scrapie-infected mice. Neurosci. Lett. 289 (2000) 173-176
10. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162 (1987) 156-159
11. Diedrich J.F., Bendheim P.E., Kim Y.S., Carp R.I., and Haase A.T. Scrapie-associated prion protein accumulates in astrocytes during scrapie infection. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 375-379
12. Diedrich J.F., Minnigan H., Carp R.I., Whitaker J.N., Race R., Frey II W., and Haase A.T. Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. J. Virol. 65 (1991) 4759-4768
13. Feng L., Xia Y., Garcia G.E., Hwang D., and Wilson C.B. Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-alpha, and lipopolysaccharide. J. Clin. Invest. 95 (1995) 1669-1675
14. Fiebich B.L., Hull M., Lieb K., Gyufko K., Berger M., and Bauer J. Prostaglandin E2 induces interleukin-6 synthesis in human astrocytoma cells. J. Neurochem. 68 (1997) 704-709
15. Floyd R.A. Neuroinflammatory processes are important in neurodegenerative diseases: an hypothesis to explain the increased formation of reactive oxygen and nitrogen species as major factors involved in neurodegenerative disease development. Free Radic. Biol. Med. 26 (1999) 1346-1355
16. Giese A., Brown D.R., Groschup M.H., Feldmann C., Haist I., and Kretzschmar H.A. Role of microglia in neuronal cell death in prion disease. Brain Pathol. 8 (1998) 449-457
17. Hirst W.D., Young K.A., Newton R., Allport V.C., Marriott D.R., and Wilkin G.P. Expression of COX-2 by normal and reactive astrocytes in the adult rat central nervous system. Mol. Cell. Neurosci. 13 (1999) 57-68
18. Ju W.K., Park K.J., Choi E.K., Kim J., Carp R.I., Wisniewski H.M., and Kim Y.S. Expression of inducible nitric oxide synthase in the brains of scrapie-infected mice. J. Neurovirology 4 (1998) 445-450
19. Kascsak R.J., Tonna-DeMasi M., Fersko R., Rubenstein R., Carp R.I., and Powers J.M. The role of antibodies to PrP in the diagnosis of transmissible spongiform encephalopathies. Dev. Biol. Stand. 80 (1993) 141-151
20. Kaufmann W.E., Worley P.F., Pegg J., Bremer M., and Isakson P. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 2317-2321
21. Kim J.I., Ju W.K., Choi J.H., Choi E., Carp R.I., Wisniewski H.M., and Kim Y.S. Expression of cytokine genes and increased nuclear factor-kappa B activity in the brains of scrapie-infected mice. Brain Res. Mol. Brain Res. 73 (1999) 17-27
22. Kumagai T., Kawamoto Y., Nakamura Y., Hatayama I., Satoh K., Osawa T., and Uchida K. 4-hydroxy-2-nonenal, the end product of lipid peroxidation, is a specific inducer of cyclooxygenase-2 gene expression. Biochem. Biophys. Res. Commun. 273 (2000) 437-441
23. Lee D.W., Sohn H.O., Lim H.B., Lee Y.G., Kim Y.S., Carp R.I., and Wisniewski H.M. Alteration of free radical metabolism in the brain of mice infected with scrapie agent. Free Radic. Res. 30 (1999) 499-507
24. Leong J., Hughes-Fulford M., Rakhlin N., Habib A., Maclouf J., and Goldyne M.E. Cyclooxygenases in human and mouse skin and cultured human keratinocytes: association of COX-2 expression with human keratinocyte differentiation. Exp. Cell Res. 224 (1996) 79-87
25. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
26. Lukiw W.J., and Bazan N.G. Strong nuclear factor-kappaB-DNA binding parallels cyclooxygenase-2 gene transcription in aging and in sporadic Alzheimer's disease superior temporal lobe neocortex. J. Neurosci. Res. 53 (1998) 583-592
27. McGeer P.L., and McGeer E.G. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Brain Res. Rev. 21 (1995) 195-218
28. McGeer P.L., Schulzer M., and McGeer E.G. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 47 (1996) 425-432
29. Mrak R.E., Sheng J.G., and Griffin W.S. Glial cytokines in Alzheimer's disease: review and pathogenic implications. Hum. Pathol. 26 (1995) 816-823
30. Murakami M., Tada K., Shimbara S., Kambe T., Sawada H., and Kudo I. Detection of secretory phospholipase A2s related but not identical to type IIA isozyme in cultured mast cells. FEBS Lett. 413 (1997) 249-254
31. Newton R., Kuitert L.M., Bergmann M., Adcock I.M., and Barnes P.J. Evidence for involvement of NF-kappaB in the transcriptional control of COX-2 gene expression by IL-1beta. Biochem. Biophys. Res. Commun. 237 (1997) 28-32
32. Nogawa S., Zhang F., Ross M.E., and Iadecola C. Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J. Neurosci. 17 (1997) 2746-2755
33. Nogawa S., Forster C., Zhang F., Nagayama M., Ross M.E., and Iadecola C. Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 10966-10971
34. Nunomura A., Perry G., Aliev G., Hirai K., Takeda A., Balraj E.K., Jones P.K., Ghanbari H., Wataya T., Shimohama S., Chiba S., Atwood C.S., Petersen R.B., and Smith M.A. Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60 (2001) 759-767
35. O'Banion M.K. Cyclooxygenase-2: molecular biology, pharmacology, and neurobiology. Crit. Rev. Neurobiol. 13 (1999) 45-82
36. O'Banion M.K., Miller J.C., Chang J.W., Kaplan M.D., and Coleman P.D. Interleukin-1 beta induces prostaglandin G/H synthase-2 (cyclooxygenase-2) in primary murine astrocyte cultures. J. Neurochem. 66 (1996) 2532-2540
37. Ohara M., Sawa T., Kurahashi K., Wiener-Kronish J.P., Doshi V., Kudoh I., and Gropper M.A. Induction of cyclooxygenase-2 in alveolar macrophages after acid aspiration: selective cyclooxygenase-2 blockade reduces interleukin-6 production. Anesthesiology 88 (1998) 1014-1022
38. Oka A., and Takashima S. Induction of cyclo-oxygenase 2 in brains of patients with Down's syndrome and dementia of Alzheimer type: specific localization in affected neurones and axons. NeuroReport 8 (1997) 1161-1164
39. O'Neill L.A., and Kaltschmidt C. NF-kappa B: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 20 (1997) 252-258
40. Park S.K., Choi S.I., Jin J.K., Choi E.K., Kim J.I., Carp R.I., and Kim Y.S. Differential expression of Bax and Bcl-2 in the brains of hamsters infected with 263K scrapie agent. NeuroReport 11 (2000) 1677-1682
41. Pasinetti G.M., and Aisen P.S. Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain. Neuroscience 87 (1998) 319-324
42. Perry G., Nunomura A., Cash A.D., Taddeo M.A., Hirai K., Aliev G., Avila J., Wataya T., Shimohama S., Atwood C.S., and Smith M.A. Reactive oxygen: its sources and significance in Alzheimer disease. J. Neural Transm., Suppl. (2002) 69-75
43. Pistritto G., Franzese O., Pozzoli G., Mancuso C., Tringali G., Preziosi P., and Navarra P. Bacterial lipopolysaccharide increases prostaglandin production by rat astrocytes via inducible cyclo-oxygenase: evidence for the involvement of nuclear factor kappaB. Biochem. Biophys. Res. Commun. 263 (1999) 570-574
44. Prusiner S.B. Prions. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 13363-13383
45. Prusiner S.B., and DeArmond S.J. Prion diseases and neurodegeneration. Annu. Rev. Neurosci. 17 (1994) 311-339
46. Rizzardini M., Chiesa R., Angeretti N., Lucca E., Salmona M., Forloni G., and Cantoni L. Prion protein fragment 106-126 differentially induces heme oxygenase-1 mRNA in cultured neurons and astroglial cells. J. Neurochem. 68 (1997) 715-720
47. Vane J.R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat. New Biol. 231 (1971) 232-235
48. Vane J.R., Bakhle Y.S., and Botting R.M. Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. Toxicol. 38 (1998) 97-120
49. Walsh D.T., Perry V.H., and Minghetti L. Cyclooxygenase-2 is highly expressed in microglial-like cells in a murine model of prion disease. Glia 29 (2000) 392-396
50. Williams A.E., van Dam A.M., Man A.H.W.K., Berkenbosch F., Eikelenboom P., and Fraser H. Cytokines, prostaglandins and lipocortin-1 are present in the brains of scrapie-infected mice. Brain Res. 654 (1994) 200-206
51. Williams A., Van Dam A.M., Ritchie D., Eikelenboom P., and Fraser H. Immunocytochemical appearance of cytokines, prostaglandin E2 and lipocortin-1 in the CNS during the incubation period of murine scrapie correlates with progressive PrP accumulations. Brain Res. 754 (1997) 171-180
52. Yamagata K., Andreasson K.I., Kaufmann W.E., Barnes C.A., and Worley P.F. Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 11 (1993) 371-386
53. Yasojima K., Schwab C., McGeer E.G., and McGeer P.L. Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs. Brain Res. 830 (1999) 226-236
54. Yasojima K., Schwab C., McGeer E.G., and McGeer P.L. Up-regulated production and activation of the complement system in Alzheimer's disease brain. Am. J. Pathol. 154 (1999) 927-936